Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
04/14/1994 | CA2145762A1 Pp14-based therapy |
04/14/1994 | CA2144850A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins |
04/14/1994 | CA2144155A1 Ibuprofen-h2 antagonist combinations |
04/14/1994 | CA2144152A1 Ibuprofen-caffine combinations |
04/14/1994 | CA2136451A1 Novel vitamin d analogues |
04/14/1994 | CA2121596A1 Novel thiosemicarbazonethiones |
04/13/1994 | EP0591528A1 PYRAZOLO 1,5-a]PYRIMIDINE DERIVATIVE AND ANTI-INFLAMMATORY CONTAINING THE SAME |
04/13/1994 | EP0591446A1 Method for treating helicobacter pylori gastritis |
04/13/1994 | EP0591263A1 Method for inhibiting adhesion of white blood cells to endothelial cells |
04/13/1994 | EP0591256A1 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-n-acetyllactosaminyl structures |
04/13/1994 | EP0446267B1 Hydroxamic acid based collagenase inhibitors |
04/12/1994 | US5302718 Compounds containing an amino salicylic acid moiety linked to a sulphapyridine moiety via stable bridge |
04/12/1994 | US5302597 Enzyme inhibitors |
04/12/1994 | US5302596 Tricyclic compounds as TXA2 antagonists |
04/12/1994 | US5302594 5-lipoxygenase inhibitors quinoxalinyl derivatives |
04/12/1994 | US5302584 Carbamates of rapamycin |
04/12/1994 | US5302384 Administering to treat inflammation |
04/12/1994 | CA1328465C Eicosanoid sulfides and their application as pharmaceutical and cosmetic compounds |
04/12/1994 | CA1328457C Compounds, pharmaceutical compositions, and methods for treating inflammation and pain |
04/12/1994 | CA1328406C Anti-inflammatory and antimicrobial formulations for dermatalogic and inflammatory diseases |
04/06/1994 | EP0591046A1 Chromene derivatives with a triene chain for use in the treatment of osteoporosis inflammatory diseases |
04/06/1994 | EP0591040A1 Quaternary basic amides as tachykinines antagonists |
04/06/1994 | EP0590558A1 Pharmaceutical composition containing 1,5,6,7-tetrahydro-4H-indazol-4-ones,new 1,5,6,7-tetrahydro-4H-indazol-4-ones and process for their manufacture |
04/06/1994 | EP0590551A2 New therapeutic uses of phthalazinone-derivatives |
04/06/1994 | EP0590403A2 Compositions having analgesic action |
04/06/1994 | EP0590051A1 Intercellular adhesion molecule-3 and its binding ligands |
04/06/1994 | EP0590009A1 Dialkyl (dialkoxyphosphinyl)methyl phosphates as anti-inflammatory agents |
04/06/1994 | EP0489116B1 Fusion proteins comprising gm-csf and il-3 |
04/06/1994 | EP0418297B1 Pharmaceutical compositions and use thereof in treating inflammation |
04/05/1994 | US5300674 Antiarthritic, antitumor agents; for osteoporosis, corneal ulceration |
04/05/1994 | US5300648 Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them |
04/05/1994 | US5300639 2-oxo-3-carbonylamino-substituted azepine intermediates; lipoperoxide formation inhibitors |
04/05/1994 | US5300522 Condensed heterocyclic compounds and pharmaceutical use thereof |
04/05/1994 | US5300504 Increasing renal fluid flow |
04/05/1994 | US5300281 Radiolabeled compositions containing a calcific matrix and their use for treatment of arthritis |
04/05/1994 | CA1328332C Peptide boronic acid inhibitors of trypsin-like proteases |
04/05/1994 | CA1328279C Catechol carboxylic acid derivatives |
04/03/1994 | CA2107548A1 Anti-arrhythmic, analgesically acting phthalazinone derivatives that break through multi-drug resistance |
03/31/1994 | WO1994006919A2 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase |
03/31/1994 | WO1994006823A1 Reagents and methods for treating rheumatoid arthritis |
03/31/1994 | WO1994006790A1 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes as paf receptor antgonists and inhibitors of 5-lipoxygenase |
03/31/1994 | WO1994006774A1 Anti-inflammatory macrolactam (cyclamenol) |
03/31/1994 | WO1994006476A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
03/31/1994 | WO1994006457A1 Pharmaceutical formulations of interleukin-1 inhibitors |
03/31/1994 | WO1994006448A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
03/31/1994 | WO1994006434A1 Method and composition for the treatment of hair loss |
03/31/1994 | WO1994006431A1 Novel epoxide-containing compounds |
03/31/1994 | WO1994001547A3 A method for generation of antibodies to cell surface molecules |
03/31/1994 | DE4244735A1 Medical use of C1 activator - to combat complications of therapy with cytokines, mediators or growth factors |
03/31/1994 | CA2145192A1 Novel epoxide-containing compounds |
03/31/1994 | CA2144747A1 New natural substance cyclamenol and chemical derivatives |
03/31/1994 | CA2144742A1 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase |
03/31/1994 | CA2144044A1 Reagents and methods for treating rheumatoid arthritis |
03/30/1994 | EP0589703A1 Proline derivative of rapamycin, production and application thereof |
03/30/1994 | EP0589556A2 Carbohydrate-based anti-inflammatory agents |
03/30/1994 | EP0589488A1 (-)-Cimaterol and its use as a medicament or growth promoter |
03/30/1994 | EP0588852A1 Immunosuppressive and tolerogenic oligosaccharide derivatives |
03/30/1994 | EP0588785A1 Urea based lipoxygenase inhibiting compounds |
03/30/1994 | CN1084408A Cyclic adhesion inhibitors |
03/30/1994 | CA2107026A1 Pharmaceutical compositions containing 1,5,6,7-tetrahydro-4h-indazol-4-ones, new 1,5,6,7-tetrahydro-4h-indazol-4-ones and processes for preparing them |
03/29/1994 | US5298522 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio |
03/29/1994 | US5298514 Phenolic thioetheramides |
03/29/1994 | US5298512 Substituted chromans and their use in the treatment of asthma, arthritis and related diseases |
03/29/1994 | US5298511 Alkanoic acid derivatives |
03/29/1994 | US5298498 Phosphonic acid derivatives useful as anti-inflammatory agents |
03/29/1994 | US5298489 DNA sequences recombinant DNA molecules and processes for producing lipocortins III, IV, V and VI |
03/29/1994 | US5298400 Genetic engineering and gene expression |
03/25/1994 | CA2106034A1 21-norrapamycin |
03/24/1994 | DE4231289A1 Neuer Naturstoff Cyclamenol und chemische Derivate New natural product cyclamenol and chemical derivatives |
03/23/1994 | EP0588655A1 Amidinophenol derivatives |
03/23/1994 | EP0588430A1 (S)-(+)-Hydroxychloroquine |
03/23/1994 | EP0588177A2 An interferon-alpha/beta binding protein, its preparation and pharmaceutical compositions containing it |
03/23/1994 | EP0587800A1 Immunomodulatory azaspiranes |
03/23/1994 | EP0587799A1 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation |
03/23/1994 | EP0587749A1 Compositions and delivery systems for transdermal administration of neutral oligomers |
03/23/1994 | EP0587735A1 T cell receptor peptides as therapeutics for immune-related disease |
03/23/1994 | EP0587673A1 Derivatives of thiopyranopyrrole and preparation thereof |
03/23/1994 | CN1084166A Substituted (benzothiazolyl-and quinoxalyl-methoxy) phenyl-acetic acid derivatives |
03/23/1994 | CN1084079A Ophthalmic compositions |
03/23/1994 | CN1084064A Formulations containing hyaluronic acid |
03/22/1994 | US5296509 Thioester enantiomeric compounds and their therapeutic uses |
03/22/1994 | US5296505 Reacting dithianepropenol with ethynyl-beta-ionol in presence of organomagnesium compound, hydrogenating triple bond, reducing diol with low-valency titanium |
03/22/1994 | US5296496 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
03/22/1994 | US5296495 Thiazolylbenzofuran derivatives and pharmaceutical composition comprising the same |
03/22/1994 | US5296486 Leukotriene biosynthesis inhibitors |
03/22/1994 | CA1327936C Phospholipase a_ inhibiting compositions and their use |
03/17/1994 | WO1994005801A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
03/17/1994 | WO1994005693A1 New aminoacid derivates, process for producing the same and pharmaceutical compositions containing these compounds |
03/17/1994 | WO1994005646A1 Optically active carboxamide derivative |
03/17/1994 | WO1994005333A1 Oligonucleotide modulation of cell adhesion |
03/17/1994 | WO1994005310A1 Peptide inhibitors of cellular adhesion |
03/17/1994 | WO1994005277A1 Multilayer controlled release tablets containing both naproxen and naproxen sodium salt |
03/17/1994 | WO1994005203A1 Biocompatible polymers containing diagnostic or therapeutic moieties |
03/17/1994 | WO1994005152A1 Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules elam-1 (e-selectin) and lecam-1 (l-selectin) |
03/17/1994 | WO1993025530A3 Vinyl arenas having retinoid-like activity |
03/17/1994 | CA2144180A1 Peptide inhibitors of cellular adhesion |
03/17/1994 | CA2144166A1 Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules elam-1 (e-selectin) and lecam-1 (l-selectin) |
03/17/1994 | CA2143748A1 Oligonucleotide modulation of cell adhesion |
03/17/1994 | CA2143449A1 Optically active carboxamide derivative |
03/17/1994 | CA2143186A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |